E Ink Joins The Climate Pledge, Highlighting Company’s Commitment to Being Net Zero Carbon By 2040
Company has also joined the Science Based Targets Initiative (SBTi ) BILLERICA, Mass.–(BUSINESS WIRE)–E Ink…
News
Pentera Appoints Nine New Members To Its Management Team As Part Of Its Global Expansion
The Company’s Management Team Expands After Becoming a Unicorn With its Latest Funding Round BOSTON…
S+S Industries’ New Facility Makes It the World’s Largest Busbar Plating Operation
Increases plating capacity to over 2,300,000 lbs per month for the power generation industry HOUSTON–(BUSINESS…
Cognito Appoints New VP to Financial Communications Practice
Taylor Fenske joins financial services agency as Vice President; Andrew Marshall relocates to New York…
E2open Introduces Strategic Advisory Board; Members to Address Supply Chain Resiliency and Solutions at CONNECT 2022
AUSTIN, Texas–(BUSINESS WIRE)–E2open Parent Holdings, Inc. (NYSE: ETWO), a leading network-based provider of a cloud-based,…
Ampco-Pittsburgh Corporation (NYSE: AP) Announces Fourth Quarter and Full Year 2021 Results
Full-year backlog growth of 19% with Forged Engineered Products backlog up 319% Full-year sales growth…
Kingston Technology Tops List of Supplier Channel SSD Shipments in 2021
Continued Growth in Q4 Solidified #1 Ranking for the Year FOUNTAIN VALLEY, Calif.–(BUSINESS WIRE)–#KingstonIsWithYou–Kingston Digital,…
Sensata Technologies Announces Strategic Collaboration with NIRA Dynamics to Develop Tire Tread Depth Monitor Solution
Sensata’s new tire Tread Depth Monitoring (TDM) solution, powered by NIRA Dynamics’ tread wear estimation…
OXIO Raises $40 Million to Launch in the U.S. and Brazil; Introduces Telecom-as-a-Service to Turn Established Brands into Telecom Carriers
Backed by Web3 Investors, Including ParaFi Capital, Digital Currency Group and Multicoin Capital, OXIO Raises…
BioNTech to Report Full Year and Fourth Quarter 2021 Financial Results and Operational Update on March 30, 2022
MAINZ, GERMANY, March 16, 2022 (GLOBE NEWSWIRE) – BioNTech SE (Nasdaq: BNTX, “BioNTech” or “the…
Mountain Valley MD Holdings Appoints Dr. Elizabeth Norton to Advisory Role to Support Key Quicksome™ Vaccine and Cold Chain Projects
TORONTO, March 16, 2022 (GLOBE NEWSWIRE) — Mountain Valley MD Holdings Inc. (the “Company” or…
LIXTE Biotechnology Holdings, Inc. to Present at MedInvest Pharmaceutical and Biotechnology Investor Conference
PASADENA, CA, March 16, 2022 (GLOBE NEWSWIRE) — LIXTE Biotechnology Holdings, Inc. (Nasdaq: LIXT), a clinical-stage…
Yield10 Bioscience Chief Executive Officer Dr. Oliver Peoples to Present on Development of Camelina Crop for Use in Biofuels at ABLC 2022 Conference
-Establishing the Camelina crop as a replenishable reserve of feedstock oil for biofuels -Winter Camelina…
BioCorRx Announces IRB Approval to Begin Phase I Clinical Trial of BICX104, an Implantable Biodegradable Naltrexone Pellet for the Treatment of Opioid Use Disorder
ANAHEIM, CA, March 16, 2022 (GLOBE NEWSWIRE) — via NewMediaWire — BioCorRx Inc. (OTCQB: BICX) (the “Company”),…
Sana Biotechnology Reports Fourth Quarter and Full Year 2021 Financial Results and Business Updates
Plans to present data at multiple scientific conferences in 2022 Expects to file INDs for…
RespireRx Pharmaceuticals Inc. Announces Discovery of a New GABAkine Neuromodulator that Protects Against Seizures and Lethality
Glen Rock, N.J., March 16, 2022 (GLOBE NEWSWIRE) — RespireRx Pharmaceuticals Inc. (OTCQ:RSPI) (“RespireRx” or…
Radius Health Announces Leadership Appointments
BOSTON, March 16, 2022 (GLOBE NEWSWIRE) — Radius Health, Inc. (“Radius” or the “Company”) (Nasdaq:…
BetterLife Obtains In Vivo PK Data for BETR-001 Confirming its Bioavailability in Brain
VANCOUVER, British Columbia, March 16, 2022 (GLOBE NEWSWIRE) — BetterLife Pharma Inc. (“BetterLife” or the…
Cytovia Therapeutics to Present Preclinical Data for iPSC-derived NK Cells and Flex-NK™ Engager Multispecific Antibodies at 2022 AACR Annual Meeting
AVENTURA, Fla. and NATICK, Mass., March 16, 2022 (GLOBE NEWSWIRE) — Cytovia Therapeutics, Inc., a biopharmaceutical…
Werewolf Therapeutics Announces Publication of Data Demonstrating the Preclinical Efficacy of WTX-124 in Delivering IL-2 Selectively to the Tumor Microenvironment
CAMBRIDGE, Mass., March 16, 2022 (GLOBE NEWSWIRE) — Werewolf Therapeutics, Inc. (the “Company” or “Werewolf”)…